Overview
International law firm McDermott Will & Emery represented Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technologies, in its acquisition of MedAlliance, a Swiss based company at the forefront of transformative drug-eluting balloons.
Cordis has a 60-year history of pioneering breakthrough cardiovascular technologies to treat millions of patients. Cordis has established a legacy of innovation in high-quality and minimally invasive cardiovascular products and built a strong global footprint with operations in more than 70 countries. Both Cordis and MedAlliance are focused on helping patients and improving the medical space through their impressive technology.
McDermott also represented Cordis in its initial investment in MedAlliance which occurred in late 2022.
The McDermott transaction team was led by Todd Finger, Bill Hadler and Taylor Berman with invaluable assistance from Michael Bruno, Ryan Forman, Rich Smith, Abigail Kagan, Kate Williams, Jacob Hollinger, Lisa Loesel, Dan O’Neil, Ryan Higgins, Li Wang, Greg Heltzer, Ty Carson, Anisa Mohanty, Sabine Nauges, Benoit Feroldi, Caroline Noyrez, Bella North, Eleanor West, Ryan Clarke and David Levine.
Read Cordis’ press release here.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
